Lv2
150 积分 2025-02-11 加入
Efficacy and Safety of Atacicept in Patients With Systemic Lupus Erythematosus
5天前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
1个月前
已完结
Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? – Authors' reply
3个月前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
3个月前
已关闭
Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension
4个月前
已完结
A phase 3, randomized, double‐blind, active‐controlled trial evaluating efficacy and safety of avatrombopag versus eltrombopag in ITP
4个月前
已完结
Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II, multicentre, prospective study
4个月前
已完结
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
4个月前
已完结
Corrections to “Management of infusion reactions to systemic anticancer therapy: ESMO Clinical Practice Guidelines”
4个月前
已完结
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study
5个月前
已完结
皖公网安备34019202002308
